NFE2L2 and cancer: An in vitro study of the human cancer cell lines A549, NCI-H292 (mucoepidermoid cells), and RERF-LC-Ai (SCC cells) (ranked from highest to lowest constitutive expression of NRF2) demonstrated that resistance to cisplatin was proportional to NRF2 expression [51].